Bank of Nova Scotia
XBI icon

Bank of Nova Scotia’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bank of Nova Scotia’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,000
Closed -$905K – 863
2019
Q1 		$905K Sell
10,000
-71,700
-88% -$6.1M ﹤0.01% 725
2018
Q4 		$5.86M Buy
+81,700
New +$6.58M 0.03% 370

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of Nova Scotia's XBI Position: Q1 2026 in Review

Bank of Nova Scotia opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 22,509 shares worth $2.87M. The stake represents 0.01% of the portfolio and ranks #681 among its holdings. This is a return to the name: Bank of Nova Scotia previously reported a position in XBI as recently as Q1 2025.

Bank of Nova Scotia first reported a position in XBI in Q1 2017 and has held it in 31 quarters since. The position peaked at $480M in Q4 2019. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Bank of Nova Scotia held 22,509 shares of State Street SPDR S&P Biotech ETF worth $2.87M as of Q1 2026.
  • State Street SPDR S&P Biotech ETF was a new Bank of Nova Scotia position in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #681 holding.
  • Bank of Nova Scotia first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 31 quarters since.
  • Bank of Nova Scotia's State Street SPDR S&P Biotech ETF position peaked at $480M in Q4 2019.
  • 815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.